The Psychosomatic Cycle of Generalized Anxiety Disorder and Chronic Illness: A Clinical Review
DOI:
https://doi.org/10.61194/jhlqr.v6i1.981Keywords:
Psychosomatic Cycle, Generalized Anxiety Disorder (GAD), Chronic Illness, Somatosensory Amplification and HypervigilanceAbstract
Generalized Anxiety Disorder (GAD) frequently coexists with chronic medical illnesses, creating a complex interaction that may intensify psychological distress and the perception of physical symptoms. This case report describes a 62-year-old male with GAD and multiple chronic comorbidities, including atherosclerotic heart disease, hypertension, type 2 diabetes mellitus with nephropathy, and benign prostatic hyperplasia. The patient presented with persistent health-related worry, sleep disturbance, and heightened preoccupation with bodily sensations, accompanied by moderate impairment in quality of life. Clinical assessment and psychological screening indicated significant anxiety symptoms without prominent depressive features. Based on clinical observations and integration with the biopsychosocial framework, somatosensory amplification, body hypervigilance, and difficulties in emotional expression were hypothesized to contribute to a psychosomatic interaction pattern. These processes may contribute to a reinforcing psychosomatic cycle in which anxiety intensifies the perception of physical symptoms, while chronic illness functions as a persistent internal stressor that maintains health-related worry. These mechanisms were not directly measured using standardized instruments but were inferred from behavioral patterns, illness narratives, and longitudinal clinical documentation. This case highlights how psychological and medical factors may mutually reinforce each other in elderly patients with multimorbidity. An integrative management approach combining pharmacological treatment, psychoeducation, and supportive psychotherapy may help interrupt this reciprocal cycle and improve functional outcomes and quality of life.
References
1. Erazo EC, Hazlett-Stevens H. Generalized Anxiety Disorder. In: Maragakis A, O’Donohue WT, editors. Principle-Based Stepped Care and Brief Psychotherapy for Integrated Care Settings. Springer; 2018. p. 203–13. doi:10.1007/978-3-319-70539-2_18
2. Mishra AK, Varma AR. A Comprehensive Review of Generalized Anxiety Disorder. Cureus. 2023;15(9). doi:10.7759/cureus.46115
3. Zhang Z. Overview on Generalized Anxiety Disorder. SHS Web of Conferences. 2024;193:3008. doi:10.1051/shsconf/202419303008
4. Zhu C. GAD Models: Intolerance of Uncertainty and Contrast Avoidance. Lecture Notes in Education Psychology. 2024;47(1):83–7. doi:10.54254/2753-7048/47/20240887
5. Putra AAG, others. Generalized Anxiety Disorder: A Literature Review. Jurnal Biologi Tropis. 2024;24:597–603. doi:10.29303/jbt.v24i1b.7958
6. Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety Disorders and Cardiovascular Disease. Curr Psychiatry Rep. 2016;18(11):101. doi:10.1007/s11920-016-0739-5
7. Kato JK. Psychological Impact of Chronic Prostate Disorders. Idosr Journal of Scientific Research. 2024;9(3):27–32. doi:10.59298/idosrjsr/2024/9.3.273200
8. Meuret AE, Tunnell N, Roque A. Anxiety Disorders and Medical Comorbidity. In: Anxiety Disorders: Rethinking and Understanding Recent Discoveries. Springer; 2020. p. 237–61. doi:10.1007/978-981-32-9705-0_15
9. Omeye FI. Psychological Impact of Chronic Prostate Disorders. Idosr Journal of Scientific Research. 2024;9(3):14–20. doi:10.59298/idosrjsr/2024/9.3.1420.100
10. Tully PJ, Baune BT. Anxiety and Cardiovascular Disease. In: Cardiovascular Diseases and Depression. Springer; 2016. p. 53–70. doi:10.1007/978-3-319-32480-7_5
11. Kumar V, Avasthi A, Grover S. Somatosensory amplification in GAD. Ind Psychiatry J. 2018;27(1). doi:10.4103/ipj.ipj_72_17
12. Nakao M, Takeuchi T. Alexithymia and somatosensory amplification. J Clin Med. 2018;7(5). doi:10.3390/jcm7050112
13. Baldwin DS, Impey B, Masdrakis V. Anxiety Disorders. In: Kingdon D, Rowlands P, Stein G, editors. Seminars in General Adult Psychiatry. 3rd ed. Cambridge University Press; 2024. p. 293–313. doi:10.1017/9781911623861.014
14. Piccoli E, others. Anxiety Disorders. In: Mental Health Research and Practice. Cambridge University Press; 2024. p. 317–40. doi:10.1017/9781009067287.019
15. Fernández R, Fontecha L, Suárez C, Gómez D, Santos I. Psychosomatic symptoms according to psychiatric diagnosis. European Psychiatry. 2023;66(S1):S299. doi:10.1192/j.eurpsy.2023.667
16. Satsangi AK, Brugnoli MP. Anxiety and psychosomatic symptoms in palliative care. Ann Palliat Med. 2018;7(1):75–111. doi:10.21037/apm.2017.07.01
17. Pedersen SS, Andersen CM. Minding the heart. Eur J Prev Cardiol. 2018;25(3):244–6. doi:10.1177/2047487317744367
18. Schmitz C, others. Heart-Focused Anxiety and Quality of Life. Front Psychiatry. 2022;13. doi:10.3389/fpsyt.2022.836750
19. Das A, Clerkin EM, Tolin DF, Assaf M, Diefenbach GJ. Moving Beyond the Negative: Contributions of Positive and Negative Affect on Quality of Life in Patients With Generalized Anxiety Disorder. J Nerv Ment Dis. 2020;208(11). doi:10.1097/NMD.0000000000001228
20. Gonzalez-Martinez A, others. Quality of life, depression, anxiety, and insomnia in epilepsy patients. Neurological Sciences. 2022;43(3):1955–64. doi:10.1007/s10072-021-05595-3
21. Michalski P, others. Quality of life and anxiety in cardiovascular risk patients. Nurs Rep. 2024;14(3):2596–604. doi:10.3390/nursrep14030191
22. Hollins M, Walters S. Experimental hypervigilance changes pressure sensations. Exp Brain Res. 2016;234(6):1377–84. doi:10.1007/s00221-015-4541-0
23. Kozlowska K, Scher S, Helgeland H. Autonomic Nervous System and Functional Somatic Symptoms. In: Functional Somatic Symptoms in Children and Adolescents. Springer; 2020. p. 119–36. doi:10.1007/978-3-030-46184-3_6
24. Perez DL, others. Neural Circuit Framework for Somatosensory Amplification. J Neuropsychiatr. 2014;27(1):e40–e50. doi:10.1176/appi.neuropsych.13070170
25. Grassi L, Wise T, Cockburn D, Caruso R, Riba MB. Psychosomatic and Biopsychosocial Medicine. In: Person Centered Approach to Recovery in Medicine. Springer; 2019. p. 19–36. doi:10.1007/978-3-319-74736-1_2
26. Bolton D. A revitalized biopsychosocial model: core theory, research paradigms, and clinical implications. Psychol Med. 2023;53(16):7504–11. doi:10.1017/S0033291723002660
27. Fava GA, Cosci F, Sonino N. Current Psychosomatic Practice. Psychother Psychosom. 2017;86(1):13–30. doi:10.1159/000448856
28. Tripathi A, Das A, Kar SK. Biopsychosocial Model in Contemporary Psychiatry. Indian J Psychol Med. 2019;41(6):582–5. doi:10.4103/IJPSYM.IJPSYM_314_19
29. Choi KY, Kim YK. Is a Combination of Pharmacotherapy and Psychotherapy Superior to Each Alone? In: Kim YK, editor. Understanding Depression: Clinical Manifestations, Diagnosis and Treatment. Springer Singapore; 2018. p. 289–303. doi:10.1007/978-981-10-6577-4_21
30. Guidi J, Fava GA. Sequential Combination of Pharmacotherapy and Psychotherapy. JAMA Psychiatry. 2021;78(3):261–9. doi:10.1001/jamapsychiatry.2020.3650
31. Dunlop BW. Evidence-Based Applications of Combination Psychotherapy and Pharmacotherapy for Depression. Focus (Madison). 2016;14(2):156–73. doi:10.1176/appi.focus.20150042
32. Gorman JM. Combining Psychodynamic Psychotherapy and Pharmacotherapy. Psychodyn Psychiatry. 2016;44(2):183–209. doi:10.1521/pdps.2016.44.2.183
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Amalia Tauziah, Hafid Algristian, Asikah

This work is licensed under a Creative Commons Attribution 4.0 International License.

